FDA Restructures Center for Drug Evaluation and Research to Improve Drug Safety and Efficiency
December 25, 2024
December 25, 2024
WASHINGTON, Dec. 25 (TNSFR) -- The Food and Drug Administration (FDA) has announced a reorganization of its Center for Drug Evaluation and Research (CDER) to streamline operations and enhance its ability to ensure medication safety. The changes, which were approved in November 2014, aim to better position the FDA to address critical public health priorities.
"The purpose of this reorganization is to strengthen OSE and OND's ability to support FDA's mission and streaml . . .
"The purpose of this reorganization is to strengthen OSE and OND's ability to support FDA's mission and streaml . . .